ARS Pharmaceuticals (SPRY) Other Gross PP&E Adjustments (2021 - 2025)
Historic Other Gross PP&E Adjustments for ARS Pharmaceuticals (SPRY) over the last 5 years, with Q3 2025 value amounting to -$1.7 million.
- ARS Pharmaceuticals' Other Gross PP&E Adjustments fell 11763.94% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year decrease of 11763.94%. This contributed to the annual value of -$1.4 million for FY2024, which is 1830.74% down from last year.
- As of Q3 2025, ARS Pharmaceuticals' Other Gross PP&E Adjustments stood at -$1.7 million, which was down 11763.94% from -$2.0 million recorded in Q2 2025.
- In the past 5 years, ARS Pharmaceuticals' Other Gross PP&E Adjustments ranged from a high of $70000.0 in Q2 2024 and a low of -$5.6 million during Q3 2021
- Its 5-year average for Other Gross PP&E Adjustments is -$1.7 million, with a median of -$1.2 million in 2023.
- Per our database at Business Quant, ARS Pharmaceuticals' Other Gross PP&E Adjustments skyrocketed by 11729.96% in 2024 and then tumbled by 301428.57% in 2025.
- Quarter analysis of 5 years shows ARS Pharmaceuticals' Other Gross PP&E Adjustments stood at -$598000.0 in 2021, then tumbled by 292.47% to -$2.3 million in 2022, then surged by 50.66% to -$1.2 million in 2023, then dropped by 18.31% to -$1.4 million in 2024, then fell by 22.48% to -$1.7 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$1.7 million for Q3 2025, versus -$2.0 million for Q2 2025 and -$460000.0 for Q1 2025.